SCHEMBL266131

SCHEMBL266131

COC(=O)c1cc2ccccc2cc1N

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.61
HSD17B10 Q99714 3/20 0.61
CFTR P13569 3/20 0.61
IDO1 P14902 1/20 0.61
KDM4E B2RXH2 7/20 0.58
HPGD P15428 6/20 0.56
GAA P10253 4/20 0.56
MAPT P10636 4/20 0.56
GLA P06280 1/20 0.56
CASP1 P29466 1/20 0.56
CASP7 P55210 1/20 0.56
ATM Q13315 1/20 0.56
ABL1 P00519 1/20 0.54
TSHR P16473 2/20 0.53
LMNA P02545 1/20 0.53
ALOX15 P16050 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A4 P31645 1/20 0.53
SLC6A3 Q01959 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30393412 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10CFTRIDO1KDM4E
SCHEMBL28685844 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10CFTRIDO1KDM4E
SCHEMBL15133575 0.86 KDM4E (0.63) ALDH1A1HSD17B10CFTRIDO1KDM4E
SCHEMBL68218 0.86 KDM4E (0.61) ALDH1A1HSD17B10CFTRKDM4EHPGD
SCHEMBL29438041 0.86 KDM4E (0.61) ALDH1A1HSD17B10CFTRKDM4EHPGD
SCHEMBL8006520 0.85 IDO1 (0.66) ALDH1A1HSD17B10CFTRIDO1KDM4E
SCHEMBL28487524 0.84 MAPT (0.57) ALDH1A1HSD17B10CFTRIDO1KDM4E
SCHEMBL28679010 0.84 MAPT (0.53) ALDH1A1HSD17B10CFTRIDO1KDM4E
SCHEMBL5253069 0.83 KDM4E (0.56) ALDH1A1HSD17B10CFTRKDM4EHPGD
SCHEMBL5254958 0.83 KDM4E (0.56) ALDH1A1HSD17B10CFTRKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4288362-A Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component BAYER AKTIENGESELLSCHAFT (DE) 1981-09-08 US claimed
US-20250100960-A1 NAPHTHALENE AND QUINOLINE ANALOGS AS RXFP1 AGONISTS BRISTOL MYERS SQUIBB CO (US) 2025-03-27 US disclosed
US-12065421-B2 Inhibitors of oplophorus luciferase-derived bioluminescent complexes PROMEGA CORPORATION (US) 2024-08-20 US disclosed
CN-118414330-A Naphthalene and quinoline analogs as RXFP1 agonists 百时美施贵宝公司 2024-07-30 CN disclosed
EP-4140991-B1 INHIBITORS OF OPLOPHORUS LUCIFERASE-DERIVED BIOLUMINESCENT COMPLEXES PROMEGA CORP (US) 2024-05-15 EP disclosed
CN-114621270-B Condensed ring aromatic compound and application thereof in electroluminescent device 清华大学 2024-04-12 CN disclosed
EP-3670515-B1 PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS OF TREATING DISORDERS DANA FARBER CANCER INST INC (US) 2024-03-06 EP disclosed
US-20230358677-A1 Reversible Excited-State Photoacids and Photobases as Dynamic Fluorescence Sensors of Protonic Species CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-11-09 US disclosed
WO-2023114818-A1 NAPHTHALENE AND QUINOLINE ANALOGS AS RXFP1 AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-06-22 WO disclosed
US-20230072421-A1 TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER BAYER AS (NO) 2023-03-09 US disclosed
EP-1242382-A1 TRICYCLIC PROTEIN KINASE INHIBITORS Wyeth (US) 2002-09-25 EP disclosed
US-20010051620-A1 Tricyclic protein kinase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 2001-12-13 US disclosed
WO-2001047892-A1 TRICYCLIC PROTEIN KINASE INHIBITORS WYETH (US) 2001-07-05 WO disclosed
US-4421601-A LACQUERS, INKS, PAINTS, TEXTILES, PAPER BAYER AKTIENGESELLSCHAFT (DE) 1983-12-20 US disclosed
US-4288362-A Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component BAYER AKTIENGESELLSCHAFT (DE) 1981-09-08 US disclosed
US-4260540-A SPIN DYEING POLYACRYLONITRILE BAYER AKTIENGESELLSCHAFT (DE) 1981-04-07 US disclosed
US-4246401-A Axomethine pigments BAYER AKTIENGESELLSCHAFT (DE) 1981-01-20 US disclosed
US-4225489-A Heterocyclic azo dyes and pigments containing 4-quinazolinone moieties BAYER AKTIENGESELLSCHAFT (DE) 1980-09-30 US disclosed
US-4014863-A LACQUERS, PRINTING INKS, PAINTS BAYER AKTIENGESELLSCHAFT (DT) 1977-03-29 US disclosed
US-3945991-A Heterocyclic azo compounds containing a quaternated hydrazide group CIBA-GEIGY AG (CH) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230072421-A1 TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER KLK3, AR, SHBG ALDH1A1 1397/4885HSD17B10 600/4885CFTR 2102/4885
US-12065421-B2 Inhibitors of oplophorus luciferase-derived bioluminescent complexes LUC7L2, LYPLAL1, GUSB ALDH1A1 1554/4885HSD17B10 1924/4885CFTR 4579/4885
US-20010051620-A1 Tricyclic protein kinase inhibitors CDK1, CHEK1, ABL1 ALDH1A1 4120/4885HSD17B10 3168/4885CFTR 4847/4885
US-20250100960-A1 NAPHTHALENE AND QUINOLINE ANALOGS AS RXFP1 AGONISTS RXFP1, RXFP2, RXFP3 ALDH1A1 1269/4885HSD17B10 1710/4885CFTR 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.